These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35322954)

  • 1. Covid-19 update: Omicron variant - a new emerging threat.
    Mehta S; Singh Gambhir R; Singh B; Goel R; Singh Ghuman K; Aggarwal A
    Rocz Panstw Zakl Hig; 2022; 73(1):13-16. PubMed ID: 35322954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.
    Parums DV
    Med Sci Monit; 2022 Feb; 28():e936199. PubMed ID: 35102132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Omicron variant: Why global communities should take it seriously?
    Rahmani S; Rezaei N
    Immun Inflamm Dis; 2022 May; 10(5):e618. PubMed ID: 35478443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Omicron Variant of the Sars-Cov-2 Virus As the Dominant Agent of a New Risk of Disease amid the COVID-19 Pandemic.
    Onishchenko GG; Sizikova TE; Lebedev VN; Borisevich SV
    Her Russ Acad Sci; 2022; 92(4):381-391. PubMed ID: 36091850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City.
    Ramírez JD; Castañeda S; Ballesteros N; Muñoz M; Hernández M; Banu R; Shrestha P; Chen F; Shi H; ; van Bakel H; Simon V; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE
    J Med Virol; 2022 Jul; 94(7):2911-2914. PubMed ID: 35243662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning point: A new global COVID-19 wave or a signal of the beginning of the end of the global COVID-19 pandemic?
    Ding K; Jiang W; Xiong C; Lei M
    Immun Inflamm Dis; 2022 Apr; 10(4):e606. PubMed ID: 35349754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 and its variants of concern including Omicron: A never ending pandemic.
    Mohapatra RK; Kuppili S; Kumar Suvvari T; Kandi V; Behera A; Verma S; Kudrat-E-Zahan ; Biswal SK; Al-Noor TH; El-Ajaily MM; Sarangi AK; Dhama K
    Chem Biol Drug Des; 2022 May; 99(5):769-788. PubMed ID: 35184391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022.
    Song P; Karako T
    Biosci Trends; 2022 Jan; 15(6):350-352. PubMed ID: 34980786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea.
    Kim MK; Lee B; Choi YY; Um J; Lee KS; Sung HK; Kim Y; Park JS; Lee M; Jang HC; Bang JH; Chung KH; Jeon J
    J Korean Med Sci; 2022 Jan; 37(3):e31. PubMed ID: 35040299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
    Kannan S; Shaik Syed Ali P; Sheeza A
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The race for a COVID-19 vaccine: where are we up to?
    Hossain MK; Hassanzadeganroudsari M; Feehan J; Apostolopoulos V
    Expert Rev Vaccines; 2022 Mar; 21(3):355-376. PubMed ID: 34937492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.